Privia Health Group, Inc. (PRVA)

Privia Health Group Stock Forecast

Stock Price Forecast

The 13 analysts that cover Privia Health Group stock have a consensus rating of "Strong Buy" and an average price target of $28.23, which forecasts a 28.49% increase in the stock price over the next year. The lowest target is $23 and the highest is $36.

Price Target: $28.23 (+28.49%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$28.23	$28	$36
Change	+4.69%	+28.49%	+27.45%	+63.86%

Analyst Ratings

The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	6	5	4	4	4	4
Buy	9	9	9	9	9	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	15	14	14	14	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Wieland Piper Sandler	Piper Sandler	Buy Maintains $35 → $36	Buy	Maintains	$35 → $36	+63.86%	Aug 11, 2025
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $30 → $28	Buy	Maintains	$30 → $28	+27.45%	Jul 9, 2025
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $29 → $32	Buy	Maintains	$29 → $32	+45.65%	May 28, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $23 → $24	Hold	Maintains	$23 → $24	+9.24%	May 27, 2025
Constantine Davides JMP Securities	JMP Securities	Buy Reiterates $29	Buy	Reiterates	$29	+32.00%	Apr 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.40B

Increased by 95.64%

from 1.74B

Revenue Next Year

3.75B

Increased by 10.27%

from 3.40B

EPS This Year

0.17

Increased by 50.02%

from 0.11

EPS Next Year

0.33

Increased by 97.35%

from 0.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	817.08M	966.22M	1.36B	1.66B	1.74B	3.40B	3.75B	4.25B
Revenue Growth	3.91%	18.25%	40.41%	22.19%	4.75%	95.64%	10.27%	13.43%
EPS	0.33	-1.83	-0.08	0.19	0.11	0.17	0.33	0.44
EPS Growth	278.92%	-	-	-	-42.11%	50.02%	97.35%	36.02%
Forward PE	-	-	-	-	-	133.13	67.46	49.60
No. Analysts	-	-	-	-	-	24	24	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.6B	4.2B	4.9B
Avg	3.4B	3.7B	4.2B
Low	3.2B	3.4B	3.8B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	107.0%	24.2%	30.9%
Avg	95.6%	10.3%	13.4%
Low	82.1%	0.8%	1.4%

EPS Forecast

EPS	2025	2026	2027
High	0.22	0.43	0.57
Avg	0.17	0.33	0.44
Low	0.09	0.22	0.37

EPS Growth

EPS Growth	2025	2026	2027
High	100.5%	160.9%	74.1%
Avg	50.0%	97.3%	36.0%
Low	-19.8%	30.6%	14.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.